Background: Non-specific chronic neck pain (NCNP) is a common musculoskeletal disorder which has caused a huge economic burden due to its expensive health costs and high re-occurrence rate. Yijinjing and Tuina are widely used for non-specific chronic neck pain in China. But there is little scientific evidence to evaluate their efficacy for NCNP. The aim of this research is to compare the efficacy of Yijinjng combined with Tuina versus Tuina for patients with NCNP. Methods/design: A randomized controlled trial in which 102 patients with non-specific chronic neck pain will be recruited and randomly allocated to either the Tuina group or the Yijinjng combined with Tuina group in a 1:1 ratio. The interventions for both groups will be carried out three times a week for 8 weeks. The patients in the two groups will receive follow-up 1 month after the intervention. The primary outcome will be the changes in the visual analog scale (VAS). Secondary outcomes will be measured by the Neck Disability Index (NDI), Self-Rating Anxiety Scale (SAS), and Tissue Hardness and Active Range of Motion (AROM). The data will be analyzed at the baseline, 4 weeks during the intervention, at the end of the intervention, and 1 month after the intervention. The significance level sets as 5%. The safety of interventions will be evaluated after each treatment session. Discussion: The purpose of this trial is to determine whether Yijinjing combined with Tuina is not inferior to Tuina for patients with NCNP. This study will provide clinicians and stakeholders much-needed knowledge for a complementary and alternative therapy for patients with non-specific chronic neck pain. Trial registration: ChiCTR registry (ChiCTR) 2000036805. Registered on August 25, 2020
Introduction Anterior Cruciate Ligament Reconstruction (ACLR) imposes substantial socioeconomic and healthcare burdens worldwide. In China, Traditional Chinese Medicine (TCM) has emerged as a popular complementary and alternative medicine strategy to relive pain and functional stability. However, the current evidence is insufficient to support the efficacy of TCM in addressing knee pain and improving physical function. This trial aims to assess the clinical effectiveness of TCM. Methods and analysis A total of 132 patients, aged between 18 and 50 years, will be recruited from Shuguang hospital. Eligible participants will be randomly allocated to either the experimental group receiving integrated TCM-Western rehabilitation intervention five sessions or the control group receiving conventional rehabilitation intervention per week. Both groups will undergo a 4-week intervention phase, followed by a 4-week follow-up period. The primary outcome measure is the change from baseline in Lysholm Score, Knee Muscle Strength, the Knee Injury and Osteoarthritis Outcome Score (KOOS), effusion, Muscle Thickness, The modified Star Excursion Balance Test (SEBT), Knee Range of Motion (ROM), Knee Proprioception. All adverse events occurring during the trial will be promptly documented. Ethics and dissemination This study protocol has been approved by the Ethics Committee of Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine (Approval Number: 2024-1522-105-01). Prior to enrollment, written informed consent will be obtained from all eligible participants in accordance with ethical guidelines. Upon study completion, findings will be disseminated through peer-reviewed publications in academic journals and presented at relevant scientific conferences to ensure broad knowledge dissemination and contribute to evidence-based clinical practice. Trial registration The trial was registered on the Chinese Clinical Trial Platform (Registration No. ChiCTR2400085239) Funding Key Supporting Discipline Construction Projects in Shanghai’s Health System (2023ZDFC0301)